Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
The American Journal of Pathology|December 26, 2003
Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumorsRainer Lehtonen, Maija Kiuru, Sakari Vanharanta, et al.
The New England Journal of Medicine|February 24, 2006
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancerHeikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Petri Bono, et al.
Nature Genetics|December 11, 2007
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repairLao H Saal, Sofia K Gruvberger-Saal, Camilla Persson, et al.
The New England Journal of Medicine|June 30, 2021
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac DiseaseDetlef Schuppan, Markku Mäki, Knut E A Lundin, et al.
Cancer Research|July 16, 2009
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinomaMatthew Maurer, Tao Su, Lao H Saal, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
The American Journal of Pathology|December 26, 2003
Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumorsRainer Lehtonen, Maija Kiuru, Sakari Vanharanta, et al.
The New England Journal of Medicine|February 24, 2006
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancerHeikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Petri Bono, et al.
Nature Genetics|December 11, 2007
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repairLao H Saal, Sofia K Gruvberger-Saal, Camilla Persson, et al.
The New England Journal of Medicine|June 30, 2021
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac DiseaseDetlef Schuppan, Markku Mäki, Knut E A Lundin, et al.
Cancer Research|July 16, 2009
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinomaMatthew Maurer, Tao Su, Lao H Saal, et al.
Pageof 15